🔎 Trials Near Me

Domov › Rakovina prsníka › Ohio › Cleveland

Klinické štúdie Rakovina prsníka v meste Cleveland, OH

35 štúdií pre Rakovina prsníka hľadá účastníkov v zariadeniach v meste Cleveland a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.

Oficiálny text štúdie (anglicky)

Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →

The Vanguard Study: Testing a New Way to Screen for Cancer

Prebieha náborVítaní zdravých dobrovoľníkov
  • Louis Stokes Cleveland VA Medical Center, Cleveland
Vek 45 až 75 · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT06995898

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Prebieha náborFáza 1/2
  • The Cleveland Clinic Taussig Cancer Center, Cleveland
Vek 12 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT04585750

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Prebieha náborFáza 2
  • Cleveland Clinic - Oncology Department, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06760819

Study of AVZO-021 in Patients With Advanced Solid Tumors

Prebieha náborFáza 1/2
  • Avenzo Therapeutics Recruiting Site, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT05867251

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Prebieha náborFáza 1/2
  • Cleveland Clinic, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT06618287

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Prebieha nábor
  • Cleveland Clinic, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT07214532

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Prebieha náborFáza 3
  • University Hospitals Cleveland Medical Center, Cleveland
  • Fairview Hospital, Cleveland
  • Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12 míľ odtiaľ
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07174336

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Prebieha náborFáza 1/2
  • UH Cleveland Medical Center, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT07109726

Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer

Prebieha nábor
  • Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland
Vek 18 až 65 · Ženy · Aktualizované 15. 9. 2026 · NCT04362826

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Prebieha náborFáza 3
  • MetroHealth, Cleveland
  • Cleveland Clinic, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT06492616

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Prebieha náborFáza 1
  • University Hospital Cleveland Medical Center, Cleveland
  • Cleveland Clinic, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT06253871

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

Prebieha náborFáza 1
  • Cleveland Clinic Foundation, Cleveland
Vek 18 až 55 · Ženy · Aktualizované 9. 9. 2026 · NCT07310420

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Prebieha náborFáza 3
  • Fairview Hospital, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • Hillcrest Hospital, Mayfield Heights · 12 míľ odtiaľ
Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06790693

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Prebieha náborFáza 3
  • Cleveland Clinic, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT06072612

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Prebieha náborFáza 3
  • Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • South Pointe Hospital, Warrensville Heights · 9 míľ odtiaľ
  • a 1 ďalších
Vek 18 až 60 · Ženy · Aktualizované 2. 9. 2026 · NCT05879926

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Prebieha náborFáza 1
  • Cleveland Clinic, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 8. 2026 · NCT07029399

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Prebieha náborFáza 1
  • Cleveland Clinic Taussig Cancer Institute, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 8. 2026 · NCT06774963

Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast

Prebieha náborFáza 2
  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
  • Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center, Cleveland
Vek 19 a viac · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT06129747

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

Prebieha náborFáza 2
  • Case Western Reserve University, Cleveland
Vek 18 až 55 · Ženy · Aktualizované 27. 7. 2026 · NCT06184750

TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients

Prebieha nábor
  • Case Western Reserve University/University Hospitals Cleveland, Cleveland
Vek 65 a viac · Ženy · Aktualizované 17. 7. 2026 · NCT05535192

Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer

Prebieha náborFáza 1
  • UHCMC Seidman Cancer Center, Cleveland
Vek 18 a viac · Ženy · Aktualizované 15. 7. 2026 · NCT05996107

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Prebieha náborFáza 1/2
  • UH Cleveland Medical Center, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 7. 2026 · NCT05768139

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Prebieha náborFáza 3
  • University Hospitals Seidman Cancer Center, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 6. 2026 · NCT05696626

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Prebieha náborFáza 2
  • Cleveland Clinic, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 6. 5. 2026 · NCT01042379

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Prebieha náborFáza 3
  • Case Western Reserve University, Cleveland
  • MetroHealth Medical Center, Cleveland
  • Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
  • a 3 ďalších
Vek 50 až 70 · Všetky pohlavia · Aktualizované 23. 4. 2026 · NCT04852887

Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer

Prebieha náborFáza 1/2
  • Cleveland Clinic, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 4. 2026 · NCT05455619

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

Prebieha náborObservačná štúdia
  • University Hospitals Seidman Cancer Center, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 2. 2026 · NCT05974150

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
  • Cleveland Clinic, Cleveland
Vek 40 a viac · Všetky pohlavia · Aktualizované 20. 1. 2026 · NCT05366881

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Prebieha náborObservačná štúdia
  • Cleveland Clinic Main Campus, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 1. 2026 · NCT06401421

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Prebieha náborObservačná štúdia
  • Massive Bio SYNERGY-AI site, Mayfield Heights · 12 míľ odtiaľ
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774

The Cancer of the Pancreas Screening-5 CAPS5)Study

Prebieha náborFáza 3
  • Case Comprehensive Cancer Center, Case Western Medical Reserve, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 10. 2025 · NCT02000089

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Prebieha náborFáza 3
  • Case Western Reserve University, Cleveland
  • Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • a 3 ďalších
Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 10. 2025 · NCT03418961

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

Prebieha náborFáza 1
  • Exelixis Clinical Site #7, Cleveland
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 9. 2025 · NCT05932862

Štúdie Rakovina prsníka v iných mestách

Iné štúdie v Cleveland

Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.